SF1
Basic information
Region (hg38): 11:64764606-64778786
Previous symbols: [ "ZNF162" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SF1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 37 | 41 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 1 | 37 | 4 | 0 |
Variants in SF1
This is a list of pathogenic ClinVar variants found in the SF1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-64765470-A-G | not specified | Uncertain significance (Jun 11, 2021) | ||
11-64765479-A-T | not specified | Uncertain significance (Nov 09, 2021) | ||
11-64765486-T-C | not specified | Uncertain significance (May 11, 2022) | ||
11-64765505-C-T | not specified | Likely benign (Feb 27, 2024) | ||
11-64766916-G-A | not specified | Likely benign (May 15, 2024) | ||
11-64767042-C-T | not specified | Likely benign (Dec 27, 2023) | ||
11-64767043-G-A | not specified | Uncertain significance (May 24, 2023) | ||
11-64767045-C-T | not specified | Likely benign (Dec 17, 2023) | ||
11-64767053-T-A | not specified | Uncertain significance (May 26, 2024) | ||
11-64767066-T-C | not specified | Likely benign (Oct 20, 2023) | ||
11-64767230-G-A | not specified | Uncertain significance (May 09, 2022) | ||
11-64767577-G-C | not specified | Uncertain significance (May 23, 2023) | ||
11-64767727-T-C | not specified | Uncertain significance (Aug 17, 2021) | ||
11-64767798-C-A | not specified | Uncertain significance (Aug 17, 2021) | ||
11-64767814-G-A | not specified | Uncertain significance (Sep 26, 2023) | ||
11-64768129-G-A | not specified | Uncertain significance (Feb 10, 2022) | ||
11-64768251-C-T | not specified | Uncertain significance (Aug 17, 2022) | ||
11-64769083-T-C | not specified | Uncertain significance (Jan 22, 2024) | ||
11-64770347-G-A | not specified | Uncertain significance (Jan 24, 2024) | ||
11-64773444-AG-A | Neurodevelopmental disorder | Likely pathogenic (May 04, 2021) | ||
11-64776521-C-A | not specified | Uncertain significance (Nov 21, 2023) | ||
11-64776534-G-A | not specified | Uncertain significance (Oct 16, 2023) | ||
11-64778004-G-A | not specified | Uncertain significance (Mar 07, 2023) | ||
11-64778010-G-A | not specified | Uncertain significance (Aug 10, 2021) | ||
11-64778013-T-C | not specified | Uncertain significance (Jun 07, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SF1 | protein_coding | protein_coding | ENST00000377387 | 13 | 14181 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.999 | 0.000569 | 120659 | 0 | 1 | 120660 | 0.00000414 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.62 | 151 | 338 | 0.446 | 0.0000202 | 4316 |
Missense in Polyphen | 16 | 108.73 | 0.14716 | 1186 | ||
Synonymous | -2.27 | 152 | 120 | 1.26 | 0.00000716 | 1456 |
Loss of Function | 4.54 | 1 | 25.9 | 0.0386 | 0.00000133 | 323 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000478 | 0.0000478 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Necessary for the ATP-dependent first step of spliceosome assembly. Binds to the intron branch point sequence (BPS) 5'-UACUAAC-3' of the pre-mRNA. May act as transcription repressor. {ECO:0000269|PubMed:10449420, ECO:0000269|PubMed:8752089, ECO:0000269|PubMed:9660765}.;
- Pathway
- Metabolism of RNA;mRNA Splicing - Major Pathway;AndrogenReceptor;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA
(Consensus)
Recessive Scores
- pRec
- 0.0867
Intolerance Scores
- loftool
- 0.0225
- rvis_EVS
- -0.87
- rvis_percentile_EVS
- 10.65
Haploinsufficiency Scores
- pHI
- 0.354
- hipred
- Y
- hipred_score
- 0.831
- ghis
- 0.612
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.995
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sf1
- Phenotype
- homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; neoplasm; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype;
Zebrafish Information Network
- Gene name
- sf1
- Affected structure
- anatomical system
- Phenotype tag
- abnormal
- Phenotype quality
- quality
Gene ontology
- Biological process
- spliceosomal complex assembly;mRNA 3'-splice site recognition;mRNA splicing, via spliceosome;male sex determination;nuclear body organization;Leydig cell differentiation;negative regulation of smooth muscle cell proliferation;regulation of steroid biosynthetic process;negative regulation of nucleic acid-templated transcription
- Cellular component
- nucleus;nucleoplasm;spliceosomal complex;ribosome;nuclear body
- Molecular function
- transcription corepressor activity;RNA binding;protein binding;zinc ion binding;identical protein binding;pre-mRNA branch point binding